Z-1936-2019 Class II Terminated

Recalled by Ortho-Clinical Diagnostics — Rochester, NY

FDA device recall Z-1936-2019 was initiated by Ortho-Clinical Diagnostics on April 8, 2019 and is designated Class II. Reason for recall: Potential negative drift in Creatine Kinase (CK) results when used on the VITROS 250 and 350 Systems. The recall status is terminated (terminated November 12, 2020). Affected quantity: 3889 units.

Recall Details

Product Type
Devices
Report Date
July 10, 2019
Initiation Date
April 8, 2019
Termination Date
November 12, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3889 units

Product Description

VITROS 350 Chemistry System, Product Code 6802153, (UDI # 10758750002054) Product Usage: Performs discrete clinical tests on serum, urine, and cerebral spinal fluid specimens. Methodologies include colorimetric (CM), potentiometric (PM), rate (RT), and immuno-rate (IR) tests using multi-layered VITROS Slides.

Reason for Recall

Potential negative drift in Creatine Kinase (CK) results when used on the VITROS 250 and 350 Systems.

Distribution Pattern

US Nationwide Distribution

Code Information

All lots